ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,389, issued on June 3, was assigned to Incyte Corp. (Wilmington, Del.).
"Formulations of an AXL/MER inhibitor" was invented by William L. Rocco (Reading, Pa.) and Francis X. Muller (Chester Springs, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to pharmaceutical formulations and dosage forms of an AXL/MER inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of AXL/MER mediated diseases such as cancer."
The patent was filed on Jan. 31, 2024, under Application No. 18/428,522.
*For further information, including im...